SG

Sigmas Group

North America, New York, United States, New York

Description

Sigmas Group

Investor Profile

Sigmas Group has made 6 investments, with 1 in the past 12 months and 17% as lead.

Stage Focus

  • Series D (17%)
  • Series C (17%)
  • Seed (17%)
  • Series B (17%)
  • Post Ipo Equity (17%)
  • Series Unknown (17%)

Country Focus

  • United States (100%)

Industry Focus

  • Health Care
  • Analytics
  • Artificial Intelligence (Ai)
  • Management Information Systems
  • Medical
  • Asset Management
  • Biotechnology
  • Data Management
  • Financial Services
  • Fintech
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Sigmas Group frequently co-invest with?

Spark Capital
North America, California, United States, San Francisco
Co-Investments: 2
SoftBank Vision Fund
Europe, England, United Kingdom, London
Co-Investments: 1
Aspenwood Ventures
North America, California, United States, San Francisco
Co-Investments: 1
Hummer Winblad Venture Partners
North America, California, United States, San Francisco
Co-Investments: 1
Concord Health Partners
North America, New Jersey, United States, Summit
Co-Investments: 1
Kohlberg Kravis Roberts
North America, New York, United States, Hudson
Co-Investments: 2
Insight Partners
North America, New York, United States, New York
Co-Investments: 2
BlackRock
North America, New York, United States, New York
Co-Investments: 1
RC
North America, Massachusetts, United States, Cambridge
Co-Investments: 3
Memorial Hermann Hospital
North America, Texas, United States, Houston
Co-Investments: 1

What are some of recent deals done by Sigmas Group?

Osyte

Seattle, Washington, United States

Osyte is a SaaS liquidity management and capital call management solution for alternative investments and private assets.

Asset ManagementData ManagementFinancial ServicesFinTechSaaSSoftwareWealth Management
SeedNov 14, 2024
Amount Raised: $4,000,000
ROME Therapeutics

Cambridge, Massachusetts, United States

ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome.

BiotechnologyHealth CarePharmaceutical
Series BSep 12, 2023
Amount Raised: $72,000,000
Greenlight Biosciences

Medford, Massachusetts, United States

GreenLight Biosciences is a biotechnology company that develops an RNA platform for agriculture and human health.

AgricultureAgTechBiotechnologyLife Science
Post Ipo EquityAug 12, 2022
Amount Raised: $109,000,000
Clarify Health Solutions

San Francisco, California, United States

Clarify Health Solutions develops an intelligence platform that delivers insights across healthcare.

AnalyticsArtificial Intelligence (AI)Health CareManagement Information SystemsMedical
Series DApr 5, 2022
Amount Raised: $150,000,000
ParkourSC

San Jose, California, United States

ParkourSC is a logistics and supply chain company that specializes in digital transformation, manufacturing, and pharmaceutical.

Asset ManagementInternet of ThingsLogisticsReal TimeSupply Chain Management
Series UnknownMar 3, 2022
Amount Raised: $26,000,000
Clarify Health Solutions

San Francisco, California, United States

Clarify Health Solutions develops an intelligence platform that delivers insights across healthcare.

AnalyticsArtificial Intelligence (AI)Health CareManagement Information SystemsMedical
Series CMar 16, 2021
Amount Raised: $115,000,000